Evotaz and Ropinirole Extended-Release Tablets
Determining the interaction of Evotaz and Ropinirole Extended-Release Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:According to the product labeling, clinically significant interactions are not expected between atazanavir and substrates of CYP450 1A2, 2A6, 2B6, 2C19, 2C9, 2D6, or 2E1. No particular precaution or dosage adjustment should be necessary.
- "Product Information. Reyataz (atazanavir)." Bristol-Myers Squibb, Princeton, NJ.
Generic Name: ropinirole
Brand name: Requip, Requip XL, ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip Starter Kit
Synonyms: Ropinirole, ROPINIRole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Evotaz-Ropinirole Hydrochloride
- Evotaz-Ropinirole Tablets
- Evotaz-Ropivacaine
- Evotaz-Ropivacaine Hydrochloride
- Evotaz-Ropivacaine Injection
- Evotaz-Rosac
- Ropinirole Extended-Release Tablets-Evoxac
- Ropinirole Extended-Release Tablets-Evzio
- Ropinirole Extended-Release Tablets-Ex-Lax
- Ropinirole Extended-Release Tablets-Ex-Lax Chocolated
- Ropinirole Extended-Release Tablets-Ex-Lax Maximum Relief Formula
- Ropinirole Extended-Release Tablets-Ex-Lax Milk of Magnesia